A Czech authorities working group on psychoactive substances has proposed a sweeping bundle of restrictions that might roll again hemp insurance policies in one in every of Europe’s most progressive markets, as regulators look like utilizing considerations over artificial hemp intoxicants to revisit broader industrial hemp reforms.
The suggestions seem to sign a radical shift within the Czech Republic underneath Prime Minister Andrej Babiš’s ANO conservative motion, which returned to energy late final yr.
Though the Babiš coalition has emphasised law-and-order insurance policies, it had up to now preserved a hashish framework that is still among the many most liberal in Europe, permitting restricted residence cultivation and possession underneath a 1.0% THC threshold for industrial hemp.
The working group’s proposals stand out as a doubtlessly vital shift, elevating questions on whether or not considerations over intoxicating cannabinoids are driving a elementary reassessment of the nation’s long-standing hemp insurance policies. The doc repeatedly refers to considerations over hemp-derived intoxicants, artificial cannabinoids and associated public-health dangers.
Business response
Key stakeholder organizations had been swift to criticize the federal government’s proposals.
“Each few months, we see the hemp sector shifting one step ahead and two steps again,” stated Francesco Mirizzi, Managing Director of the European Industrial Hemp Affiliation (EIHA). “Such regulatory swings discourage funding, gradual innovation and create uncertainty all through the worth chain.”
Hana Gabrielová, President of CzecHemp, a nationwide trade cluster, stated “It’s vital to differentiate between pure industrial hemp from licensed European varieties, and synthetically modified merchandise that pose an actual well being threat.
“Furthermore, pure hemp flowers — an important supply of cannabinoids for the human physique — shouldn’t be pushed onto the black market,” she stated.
1% THC in danger
The suggestions, contained in a coverage paper ready by the Interdepartmental Working Group on the Concern of Psychoactive Substances, would decrease the nation’s hemp THC restrict from 1.0% again to 0.3%, remove exemptions for hemp extracts, think about restrictions on cannabinoid extraction, and doubtlessly ban CBD and different cannabinoids in meals.
The proposals usually are not legislation, but the doc outlines particular authorized adjustments, assigns duty to ministries and companies, and establishes implementation timelines stretching into 2028.
The importance extends nicely past the cannabinoid sector. If adopted, a number of of the suggestions would instantly have an effect on hemp cultivation, breeding, processing and product growth, reaching far past the intoxicating merchandise that dominate the paper’s rationale.
The proposed restrictions may negatively influence the cosmetics trade, the veterinary sector, hemp analysis, and the authorized manufacturing of non-psychoactive merchandise from the hemp seed and hemp stalk.
HHC issue
The working group argues that the Czech Republic’s present framework has been exploited for the sale of potent intoxicating merchandise and for exports which have drawn scrutiny from regulators elsewhere in Europe. It repeatedly cites enforcement challenges, youth entry considerations and the emergence of recent psychoactive substances as justification for tighter controls. The paper factors particularly to hexahydrocannabinol (HHC).
EIHA’s Mirizzi stated it’s “significantly regarding that industrial hemp is more and more paying the worth for the actions of operators who exploit its repute to market harmful substances like HHC. By associating these merchandise with hemp, they create confusion amongst shoppers and policymakers alike, finally harming an agricultural crop that has monumental potential for meals, fiber, development supplies and the broader bioeconomy.”
The Czech Republic turned one in every of Europe’s largest and most seen HHC markets. Regulators spent the final two years attempting to reply to HHC, semi-synthetic cannabinoids and different new-era psychoactive substances. The nation additionally created a novel regulatory class for “psychomodulatory substances” to take care of merchandise that didn’t match conventional drug-control frameworks.
“The answer is to not roll again progressive hemp insurance policies, however to implement present guidelines in opposition to unlawful and non-compliant merchandise. Industrial hemp shouldn’t turn out to be collateral injury in a debate largely pushed by substances which can be far faraway from the normal hemp plant,” Mirizzi stated.
The considerations over HHC usually are not distinctive to the Czech Republic. Governments throughout Europe have struggled to reply to the favored artificial intoxicant and comparable compounds that emerged from hemp-derived CBD.
The United Nations Fee on Narcotic Medicine categorized HHC as an internationally managed substance in March 2025, putting it in Schedule II of the 1971 Conference on Psychotropic Substances.
‘Precursor’ speak
The paper additional means that Czech authorities ought to actively pursue efforts on the European degree to categorise CBD as a drug precursor. The advice comes amid a global debate over CBD’s position as a feedstock for HHC and different semi-synthetic cannabinoids, highlighted in a February 2026 discover from the Worldwide Narcotics Management Board.
Scientifically, there’s little dispute that CBD can function a precursor to HHC and different semi-synthetic cannabinoids as a result of it’s routinely used because the beginning materials in chemical conversion processes that produce intoxicating compounds. In that slender technical sense, CBD is certainly a precursor.
However CBD is just not categorized as a drug precursor underneath worldwide drug-control conventions and isn’t scheduled as a narcotic or psychotropic substance. The talk is due to this fact not whether or not CBD will be transformed into intoxicants, however whether or not that truth justifies regulating CBD itself as a precursor chemical.
Standing in Europe
The Czech proposal displays rising concern over HHC and associated compounds whereas marking a shift away from the normal worldwide method to CBD as a non-intoxicating cannabinoid.
However the suggestions additionally seem to run in opposition to the development in European case legislation. Within the landmark Kanavape ruling, the Court docket of Justice of the European Union held that CBD is just not a narcotic and that member states might not block the free motion of hemp-derived merchandise lawfully produced elsewhere within the EU. Extra just lately, the courtroom has been requested to weigh Italy’s restrictions on hemp flowers and CBD, a case extensively seen as one other check of the EU’s established authorized framework for industrial hemp merchandise.
Regression
What makes the Czech proposals notable is the extent to which the really helpful treatments attain into the complete hemp sector. The doc’s most consequential proposal for industrial hemp would reverse the nation’s 2022 choice to lift the THC threshold to 1.0%.
That reform was extensively seen as a milestone for European hemp. Supporters argued that the upper threshold higher mirrored agricultural realities, diminished the danger of crop destruction, expanded entry to genetics and improved competitiveness for growers.
A return to 0.3% would transfer the Czech Republic again towards the usual adopted by most European nations, and heighten considerations amongst farmers about crops exceeding the THC restrict underneath excessive climate situations.
Wider influence
The working group additionally recommends reconsidering exemptions for hemp extracts and tinctures, evaluating restrictions on cannabinoid extraction, and contemplating a blanket prohibition on meals containing CBD, cannabigerol (CBG) and cannabinol (CBN).
The Czech drug group’s proposal would goal a sector that has already largely exhausted its development prospects in Europe. The once-booming marketplace for non-prescription CBD merchandise has steadily retreated underneath the burden of novel meals necessities, regulatory uncertainty and enforcement pressures, leaving pharmaceutical purposes because the trade’s solely viable long-term pathway.
Taken collectively, the suggestions would signify some of the restrictive coverage shifts proposed by any European authorities lately.
Lacking context
Whereas the doc accommodates intensive dialogue of psychoactive substances, enforcement mechanisms, product seizures, administrative powers and public-health protections, it’s quick on any significant evaluation of how the proposed adjustments may have an effect on industrial hemp companies working exterior the intoxicating cannabinoid market.
There’s little dialogue of hemp farming, fiber manufacturing, grain markets, rural growth, industrial processing, funding or the bioeconomy.
The paper additionally doesn’t talk about how a decrease THC threshold may have an effect on breeding applications, cultivar choice or future funding in hemp agriculture. Nor does it assess how such adjustments may have an effect on Czech growers’ competitiveness relative to producers working underneath extra permissive hemp frameworks exterior the nation.
